Cita APA (7a ed.)

Ferragut, F., Cagnoni, A., Colombo, L., Sánchez Terrero, C., Wolfenstein-Todel, C., Troncoso, M., . . . Elola, M. Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.

Cita Chicago Style (17a ed.)

Ferragut, F., et al. Dual Knockdown of Galectin-8 and Its Glycosylated Ligand, the Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), Synergistically Delays in Vivo Breast Cancer Growth.

Cita MLA (8a ed.)

Ferragut, F., et al. Dual Knockdown of Galectin-8 and Its Glycosylated Ligand, the Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), Synergistically Delays in Vivo Breast Cancer Growth.